Accucaps maker describes need for gel-cap manufacturing finesse

"This is an industry that relies on your brains, not your brawn," says ops VP Glen Harron of gel-cap maker Accucaps. "It relies on a very self-disciplined workforce. People need to keep a slow, methodical pace; you need to be accurate, accurate, accurate." Story

Suggested Articles

Cadila Healthcare is looking for outside manufacturing partners to add 70 million doses of its experimental COVID-19 vaccine to its arsenal.

The COVID-19 pandemic has disrupted another biopharma company's plan to launch a new medicine.

Two prominent pneumococcal vaccines from Merck and Pfizer are running low in Europe in a possible ill omen for the coming winter: report.